Burkhard Schaefer, Managing Director of Splashlake, explores how chromatography is being impacted by emerging data standards. In drug discovery, every inefficiency in experimental workflows costs time, money, and the chance to bring life-saving treatments to patients. Chromatography has long been hampered by data silos, proprietary formats, and disconnected instrumentation. But that is changing now. Scientific […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!